1. Home
  2. IVA vs MLAB Comparison

IVA vs MLAB Comparison

Compare IVA & MLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inventiva S.A. American Depository Shares

IVA

Inventiva S.A. American Depository Shares

SELL

Current Price

$3.12

Market Cap

796.1M

Sector

Health Care

ML Signal

SELL

Logo Mesa Laboratories Inc.

MLAB

Mesa Laboratories Inc.

SELL

Current Price

$127.88

Market Cap

719.9M

Sector

Industrials

ML Signal

SELL

Company Overview

Basic Information
Metric
IVA
MLAB
Founded
2011
1982
Country
France
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
796.1M
719.9M
IPO Year
2020
1995

Fundamental Metrics

Financial Performance
Metric
IVA
MLAB
Price
$3.12
$127.88
Analyst Decision
Strong Buy
Buy
Analyst Count
12
3
Target Price
$15.20
★ $117.50
AVG Volume (30 Days)
★ 2.3M
91.2K
Earning Date
09-28-2026
11-05-2026
Dividend Yield
N/A
★ 0.50%
EPS Growth
N/A
★ 436.11
EPS
N/A
★ 0.49
Revenue
N/A
N/A
Revenue This Year
N/A
$2.14
Revenue Next Year
N/A
$6.45
P/E Ratio
★ N/A
$260.98
Revenue Growth
N/A
N/A
52 Week Low
$3.11
$67.89
52 Week High
$7.98
$144.35

Technical Indicators

Market Signals
Indicator
IVA
MLAB
Relative Strength Index (RSI) 32.53 49.29
Support Level N/A $89.77
Resistance Level $4.80 $132.70
Average True Range (ATR) 0.25 5.13
MACD -0.00 -1.26
Stochastic Oscillator 3.08 14.59

Price Performance

Historical Comparison
IVA
MLAB

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based clinical-stage biopharmaceutical company focused on the development of oral small-molecule therapies for the treatment of MASH. The wholly-owned research and development facility and a team with expertise and experience in the development of compounds that target nuclear receptors, transcription factors and epigenetic modulation. Leveraging the expertise, the company is also advancing lanifibranor for the treatment of MASH and has a pipeline of earlier-stage therapeutic programs in oncology. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France.

About MLAB Mesa Laboratories Inc.

Mesa Laboratories Inc manufactures life sciences tools and critical quality control solutions. It operates in four divisions: i) Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. ii) Clinical Genomics division develops, manufactures, and sells sensitive, low-cost, high-throughput genetic analysis tools and related consumables. iii) The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. iv) The Calibration Solutions division develops, manufactures, sells, and services quality control products.

Share on Social Networks: